Alteogen signs deal with Novartis worth up to 4.4 tln won for subcutaneous formulations

Yonhap News

SEOUL, Sept. 2 (Yonhap) -- South Korean biotechnology company Alteogen Inc. said...

SEOUL, Sept. 2 (Yonhap) -- The number of voice phishing cases fell nearly 40 per...

SEOUL, Sept. 2 (Yonhap) -- Defense Minister Ahn Gyu-back said Wednesday the mili...

SEJONG, Sept. 2 (Yonhap) -- South Korea's finance minister outlined Seoul's visi...

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play